A Glance At 2 Infant Milk Formula Stocks – JAT, WHA

Changing lifestyles, increasing women working population and rising demand for organic food products would drive infant milk formula market in Australia in the coming years. Though the market is registering strong demand from Asia, especially Chinese region, the infant milk formula stocks in Australia are expected to feel the heat of global trends like the US-China trade war and China’s plan to boost its domestic infant milk formula production in the coming years.

With the impending trade war between the United States and China, worries among Australian players are increasing, as the former is Australia’s number one investor, while the latter is its number one trading partner. According to data from the Department of Foreign Affairs and Trade of the Australian government, China accounted for over 30% of its exports in 2018. The growing trade tensions between the two economies might result in some challenges for Australian companies, as it is likely to have a global economic impact.

Meanwhile, China’s National Development and Reform Commission has also revealed a plan to increase the share of domestic infant milk formula market to 60% in its total infant-formula industry. China intends to improve the Chinese made infant formula quality, as it aims to boost consumer confidence and satisfaction in infant formula products produced, within the country after the 2008 deadly milk scandal, in which milk and infant formula in addition to other food materials and components were found to be adulterated with melamine, a toxic industrial compound. The incident led to six fatalities and sickened an estimated 300,000 babies, as they consumed the contaminated formula. Further, the Asian country plans to encourage its people to purchase domestically manufactured products, in order to trim down its dependence on imported infant formula products. Though China is yet to share a timeframe regarding its plan, such market developments are resulting in fears of losing demand from the global market among Australian players.

Let us have an overview of recent updates from two ASX-listed infant milk formula players – JAT and WHA:

Jatenergy Limited

Incorporated in 2006, Jatenergy Limited (ASX: JAT) is an end-to-end export service provider, catering to Australian companies seeking to position their footprints in the Chinese market. JAT assists its customers in obtaining necessary regulatory approvals, in addition to getting fast and cost-effective entry into wholesaler and shopping platforms such as TMall and Alibaba. Moreover, the company helps in fundraising from investors like investment banks, managed funds and private individuals. The company, which is headquartered at Chatswood, Australia, holds important import licenses, as well as has access to top level contacts and distribution channels. The company sells products such as milk powder oats, cereals, wine, nutraceuticals, cleaning products, biscuits produced by Australian companies.

Sponsored ad by Kalkine

On 11 June 2019, Jatenergy Limited notified the market that its subsidiary, Sunnya Pty Ltd, has developed three new goat milk infant formulas under Neurio. To be sold in China, Hong Kong and Macao, the three formulas would cater to three child development stages. The three products are Neurio Goat Infant Formula, Neurio Goat Follow-on Formula and Neurio Goat Formulated supplementary food for young children, respectively. Products under Neurio are produced in Australia ensuring high product quality and represent the company’s product range expansion. Moreover, the new product launch follows success of Neurio lactoferrin series products.

“We have successfully developed Neurio baby lactoferrin, Middle-Aged lactoferrin and we are now having a high-quality goat milk infant formula for the Chinese and other markets. The offtake arrangement and funding security clearly show that Neurio is a trustworthy and valuable brand in both Australia and China. We at Sunnya have great confidence that Neurio goat infant formula will be another popular product in the Chinese market”, said Sunnya’s Managing Director, Wilton Yao.

BSC Trading, a China-based distributor, will distribute the products, through e-commerce channels. Sunnya has received the first order worth A$650,000, including a security deposit. The company will make its first product shipment in August 2019.

According to estimates, a huge portion of population in China has some degree of intolerance to cow lactose and allergy to cow milk protein. Also, the Chinese population has a lower goat milk lactose intolerance to goat milk powder formula.

Separately, on 6 June 2019, Jatenergy Limited announced that along with its subsidiaries, the company has secured special goods orders worth A$2.7 million from several China-based platforms including major maternal stores and pharmacies. The orders are specifically for China’s 618 shopping festival, which was founded on 18 June 1998, and is one of the most prominent e-commerce festivals in the country.

Stock Performance:

JAT has a market capitalisation of A$43.32 million. The stock noted a 52-week high of A$0.125 and 52-week low of A$0.035 (as on 14 June 2019). The stock reported a negative YTD and 6M return of 19.12% and 17.91%. The company’s stock last traded at A$0.052, down by 1.887 (as on 14 June 2019).

Wattle Health Australia Limited

As a provider of products that related to health and wellness, Wattle Health Australia Limited (ASX: WHA) majorly focuses on producing products that are prepared by using locally grown, natural or certified organic ingredients. The company is engaged in developing products that offers scientific and nutritional benefits and adhere to strict global standards. These products include full cream dried milk powder and domestic infant formulas. WHA aims to become a globally recognised company for its organic and sustainable products. Founded in 2011, the company is headquartered at Victoria, Australia.

On 23 May 2019, Wattle Health Australia Limited updated ASX, regarding the dedicated organic nutritional spray dryer construction project undertaken by Corio Bay Dairy Group (CBDG), a JV between WHA, Niche Dairy (ND) and The Organic Dairy Famers of Australia (ODFA).

According to the progress update, head builder George Rydell Constructions is currently carrying out the construction at CBDG and steel works for the dryer and evaporator building, in order to lay concrete on the first two levels of the building, which will have a circa 28-meter height after completion. The company is set to start deploying concrete panels of the dryer and the evaporator building in the coming weeks before the first shipment arrival. Of the five shipments of the dryer/evaporator equipment, the first shipment is due to arrive in late-July 2019 from overseas.

The dryer is the first of its kind in Australia. Once operational, the dryer will process the largest pool of fresh organic milk. The processing will be carried out under an exclusive supply agreement with ODFA. Also, Wattle Health Australia Limited has reached a deal, giving it the exclusive rights to supply CBDG-produced products for use across its nutritional dairy range.

Stock Performance:

With a market cap of A$105.03 million, the stock last traded at A$0.555 on 14 June 2019, up 2.778% from the previous close. The number of WHA shares traded today were 100,765. The stock had a 52-week low of A$0.530 and 52-week high of A$1.655. The YTD return stands at negative 40.66%, also, the stock registered a negative 40.66% return in the past six-month period.

Also, Jatenergy Limited and Wattle Health Australia Limited’s, stock performance in last 6-months have been depicted in the image below:  


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice. 

Facebook Comments

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here